Multi Ways Holdings Ltd
For the period ended Oct 2, 2024. Filed Oct 2, 2024.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 2, 2024 · Filed Oct 2, 2024
Use the contents to explore the available documents and sections.
Contents
EX-99.2 · PROXY
PROXY
**Solicited on Behalf of the Board of Directors for the Annual General Meeting of Shareholders
on October 30, 2024, at 02:00 p.m. Singapore Time (October 30, 2024, at 02:00 a.m. Eastern Time),
The undersigned hereby appoints Lim Eng Hock as proxy with full power of substitution, to represent and to vote as set forth herein all the ordinary shares ofMulti Ways Holdings Limited which the undersigned is entitled to vote at the Annual General Meeting of Shareholders and any adjournments or postponements thereof, as designated below.If no designation is made, the proxy, when properly executed, will be voted “FOR” in Items 1, 2, 3, 4, 5, 6 and 7.
| Item 1 | By an ordinary resolution, to re-appoint five directors, Mr. Lim Eng Hock, Ms. Lee Noi Geck, Mr. Chan Chin Hoong, Mr. Wong Gang, and Mr. Neo Chin Heng, to serve on the Company’s board of directors (the “Board”) until the next annual general meeting of shareholders or until their office is otherwise vacated or they are removed by an ordinary resolution of the shareholders or by a resolution of the remaining directors. |
|---|
| Lim Eng Hock | ☐ For | ☐ Against | ☐ Abstain |
|---|---|---|---|
| Lee Noi Geck | ☐ For | ☐ Against | ☐ Abstain |
| Chan Chin Hoong | ☐ For | ☐ Against | ☐ Abstain |
| Wong Gang | ☐ For | ☐ Against | ☐ Abstain |
| Neo Chin Heng | ☐ For | ☐ Against | ☐ Abstain |
| Item 2 | By an ordinary resolution, to approve the appointment of Onestop Assurance PAC as the Company’s independent registered public accounting firm for the fiscal year ending in December 31, 2024. | ||
|---|---|---|---|
| ☐ For | ☐ Against | ☐ Abstain | |
| Item 3 | By an ordinary resolution, to approve and adopt the Company’s 2024 Equity Incentive Plan and all transactions contemplated thereunder, including the reservation and issuance of shares. | ||
|---|---|---|---|
| ☐ For | ☐ Against | ☐ Abstain | |
| Item 4 | By an ordinary resolution, to approve an increase of the Company’s authorized share capital from US$100,000 divided into 400,000,000 shares of a nominal or par value of US$2,500,000 divided into 10,000,000,000 shares of a nominal or par value of US$0.00025 each by the creation of an additional 9,600,000,000 shares of a nominal or par value of US$0.00025 each. | ||
|---|---|---|---|
| ☐ For | ☐ Against | ☐ Abstain | |
| Item 5 | By an ordinary resolution, to approve a share consolidation of the Company’s issued and unissued Ordinary Shares be approved at a ratio of not less than one (1)-for-three (3) and not more than one (1)-for-twenty-five (25) (the “Range”), with the exact ratio to be set at a whole number within this Range to be determined by the Board in its sole discretion within one year after the date of passing of these resolutions. | ||
|---|---|---|---|
| ☐ For | ☐ Against | ☐ Abstain | |
| Item 6 | , By a special resolution, to approve and adopt the Second Amended and Restated Memorandum and Articles of Association of the Company. | ||
|---|---|---|---|
| ☐ For | ☐ Against | ☐ Abstain | |
| Item 7 | By an ordinary resolution, to adjourn the Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal One, Proposal Two, Proposal Three, Proposal Four, Proposal Five and Proposal Six | ||
|---|---|---|---|
| ☐ For | ☐ Against | ☐ Abstain | |
In his discretion, the proxy is authorized to vote upon any other matters which may properly come before the Annual Meeting, or any adjournment or postponement thereof.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.